Companion Diagnostics Market - Global Industry Analysis 2024
Get Free PDF Research Brochure for more Professional and Technical Insights: https://www.coherentmarketinsights.com/insight/request-sample/109
Companion diagnostics are beneficial for pharmaceutical companies who face challenges with respect to high drug development cost, safety and outcome of clinical trials, and long product approval time. Companion diagnostics lowers development costs, improves time to market and enhances drug safety by enabling rapid identification of target biomarker and the most effective drug therapy. For patients, the technology provides better treatment outcomes and lower morbidity risk. Use of technologies such as PCR, immunohistochemistry, and gene sequencing has enabled accurate diagnosis and determination of targeted cancer therapy. As the CDx tests also aid in revealing the off-target effects of a drug along with identification of a molecular target, CDx have become and indispensable tool for oncologists.
This report segments the global companion diagnostics market on the basis of application, technology, and geography. On the basis of application, the market is categorized into breast cancer, lung cancer, colorectal cancer, gastric cancer, melanoma, and others. On the basis of technology, the market is segmented into immunohistochemistry, real-time PCR, gene sequencing, Fluorescence in situ hybridization (FISH), and others. For comprehensive understanding of market dynamics, the global companion diagnostics market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
Key features of the study:
-This report provides in-depth analysis of the companion diagnostics and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 – 2024, considering 2015 as the base year
-It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
-It profiles leading players in the global companion diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Browse Global Strategic Business Report : https://www.coherentmarketinsights.com/market-insight/companion-diagnostics-market-109
-Key companies covered as a part of this study include Abbott Laboratories, Inc., Agilent Technologies, Inc., Danaher Corporation, GE Healthcare, Qiagen N.V., Roche Diagnostics, Myriad Genetics, Inc., bioMérieux SA, Illumina, Inc. and Siemens Healthcare
-Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, technology upgrades, market expansion, and marketing tactics
-The global companion diagnostics market report caters to various stakeholders in this industry, including investors, device manufacturers, distributors and suppliers for companion diagnostics, research and consulting firms, new entrants, and financial analysts
-Various strategy matrices used in analyzing the companion diagnostics market would provide stakeholders vital inputs to make strategic decisions accordingly
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Companion Diagnostics Market - Global Industry Analysis 2024 here
News-ID: 447366 • Views: 130
More Releases from Companion Diagnostics Market
Companion Diagnostics Market Size 2020-26, QIAGEN, Agilent, BioMerieux
The latest study on the Global Companion Diagnostics market report represents a deep appraisal of the international industry. The research report on the worldwide Companion Diagnostics market 2020-2026 sheds light on qualitative as well as quantitative insights, historical Companion Diagnostics industry status and authorized projection related to the Companion Diagnostics market size. Each and every segment exhibited in this report are discovered through verifiable research methods and techniques. It also
Companion Diagnostics Market to Witness Steady Growth at 32.3% CAGR During 2016 …
Researchmoz added Most up-to-date research on "Companion Diagnostics: Technologies and Markets" to its huge collection of research reports. Report Highlights The global market for companion diagnostics reached nearly $3.2 billion in 2015. This market is expected to increase from $4.3 billion in 2016 to nearly $17.6 billion in 2021 at a compound annual growth rate (CAGR) of 32.3% for 2016-2021. Report Includes An overview of the market for companion diagnostics, including existing products on
Companion Diagnostics Market - Analysis And Forecast (2016-2024): Market Shares …
Companion diagnostic (CDx) is a diagnostic tool used to determine the suitability of a drug therapy to the patient. It has become a critical part of targeted cancer therapy that allows for development of personalized therapy can be developed and administered to the patient. Whole blood samples, tissues samples, or buccal samples are collected and tested for diagnosis and identification of targeted disease biomarker. CDx is usually utilized in identifying
CMI Releases New Report on the Companion Diagnostics Market,2017-2024.
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic
More Releases for CDx
Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Mark …
This report studies the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market by companies, region, type and end-use industry. Get Sample Copy of This Report @ https://www.researchtrades.com/request-sample/1644663 In 2017, the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market size was million US$ and it is expected to reach million US$ by the end of 2025,
The companion diagnostics (CDx) market is projected to grow with a good CAGR dur …
The recent study on the companion diagnostics market covers an in-depth analysis of the market on the basis of technology, indication, and geography. The report also covers the country level analysis within the regions as well. In addition, the report covers the key trends in the market along with drivers and restraints during the forecast period 2018-2023. According to the report titled “Companion Diagnostics (CDx) Market - Forecasts From 2018
Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market 2018 …
The Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market 2018 to 2025 renders deep perception of the key regional market status of the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Industry on a global level that primarily aims the core regions which comprises of continents like Europe, North America, and Asia and the key countries such as United States, Germany, China and Japan. The report on “Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market” is a professional report
Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Sale …
This report studies the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market, analyzes and researches the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Qiagen NV GE Healthcare Agilent Technologies F Hoffman La Roche Foundation Medicine Thermo Fisher Scientific Inc. Leica Biosystems Nussloch GmBH Pfizer Get the sample copy of report : https://www.marketresearchreports.biz/sample/sample/1486733 Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast
Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Mark …
Qyresearchreports include new market research report "Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size,Status and Forecast 2025" to its huge collection of research reports. The report on the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market covers all major factors such as growth drivers, leading segments, market size estimates, and technological advancements for the 2018-2025 forecast period. These factors hold significance for a qualitative and quantitative analysis of the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market
Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size …
This report provides in depth study of “Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of